JP2005506833A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506833A5 JP2005506833A5 JP2003502172A JP2003502172A JP2005506833A5 JP 2005506833 A5 JP2005506833 A5 JP 2005506833A5 JP 2003502172 A JP2003502172 A JP 2003502172A JP 2003502172 A JP2003502172 A JP 2003502172A JP 2005506833 A5 JP2005506833 A5 JP 2005506833A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- cell
- acid molecule
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 53
- 108090000765 processed proteins & peptides Proteins 0.000 claims 53
- 229920001184 polypeptide Polymers 0.000 claims 52
- 238000000034 method Methods 0.000 claims 35
- 150000007523 nucleic acids Chemical class 0.000 claims 28
- 108020004707 nucleic acids Proteins 0.000 claims 24
- 102000039446 nucleic acids Human genes 0.000 claims 24
- 210000004027 cell Anatomy 0.000 claims 23
- 239000000523 sample Substances 0.000 claims 15
- 241001465754 Metazoa Species 0.000 claims 10
- 230000003902 lesion Effects 0.000 claims 10
- 125000003275 alpha amino acid group Chemical class 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 239000000126 substance Substances 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000013068 control sample Substances 0.000 claims 4
- 108700019146 Transgenes Proteins 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 241000238631 Hexapoda Species 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 230000001594 aberrant effect Effects 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 230000003334 potential effect Effects 0.000 claims 2
- 229940124606 potential therapeutic agent Drugs 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 210000005253 yeast cell Anatomy 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 238000010494 dissociation reaction Methods 0.000 claims 1
- 230000005593 dissociations Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
Applications Claiming Priority (30)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29560701P | 2001-06-04 | 2001-06-04 | |
| US29640401P | 2001-06-06 | 2001-06-06 | |
| US29641801P | 2001-06-06 | 2001-06-06 | |
| US29657501P | 2001-06-07 | 2001-06-07 | |
| US29741401P | 2001-06-11 | 2001-06-11 | |
| US29756701P | 2001-06-12 | 2001-06-12 | |
| US29757301P | 2001-06-12 | 2001-06-12 | |
| US29828501P | 2001-06-14 | 2001-06-14 | |
| US29855601P | 2001-06-15 | 2001-06-15 | |
| US29852801P | 2001-06-15 | 2001-06-15 | |
| US29913301P | 2001-06-18 | 2001-06-18 | |
| US29923001P | 2001-06-19 | 2001-06-19 | |
| US29994901P | 2001-06-21 | 2001-06-21 | |
| US30017701P | 2001-06-22 | 2001-06-22 | |
| US30153001P | 2001-06-28 | 2001-06-28 | |
| US30155001P | 2001-06-28 | 2001-06-28 | |
| US30295101P | 2001-07-03 | 2001-07-03 | |
| US31877101P | 2001-09-12 | 2001-09-12 | |
| US32468701P | 2001-09-25 | 2001-09-25 | |
| US33926601P | 2001-10-24 | 2001-10-24 | |
| US33752401P | 2001-11-16 | 2001-11-16 | |
| US34114301P | 2001-12-14 | 2001-12-14 | |
| US35915102P | 2002-02-21 | 2002-02-21 | |
| US35864302P | 2002-02-21 | 2002-02-21 | |
| US36119502P | 2002-02-28 | 2002-02-28 | |
| US36196402P | 2002-03-05 | 2002-03-05 | |
| US37134602P | 2002-04-10 | 2002-04-10 | |
| US37152302P | 2002-04-10 | 2002-04-10 | |
| US10/161,493 US20040018555A1 (en) | 2001-06-04 | 2002-06-03 | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| PCT/US2002/017559 WO2002099062A2 (en) | 2001-06-04 | 2002-06-04 | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506833A JP2005506833A (ja) | 2005-03-10 |
| JP2005506833A5 true JP2005506833A5 (enrdf_load_stackoverflow) | 2006-01-05 |
Family
ID=30773846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003502172A Pending JP2005506833A (ja) | 2001-06-04 | 2002-06-04 | 抗原性ポリペプチドに結合する新規抗体、抗原をコード化する核酸、および使用方法 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1401470A4 (enrdf_load_stackoverflow) |
| JP (1) | JP2005506833A (enrdf_load_stackoverflow) |
| CA (1) | CA2447935A1 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090074780A1 (en) * | 2007-06-25 | 2009-03-19 | David Urech | Methods of modifying antibodies, and modified antibodies with improved functional properties |
| TW201627003A (zh) * | 2010-04-02 | 2016-08-01 | 腫瘤療法 科學股份有限公司 | Ect2胜肽及含此胜肽之疫苗 |
| CN113604480B (zh) * | 2021-09-17 | 2023-07-04 | 四川农业大学 | 一种玉米转录因子ZmHsf28及应用 |
| CN120399671B (zh) * | 2025-07-03 | 2025-09-30 | 铜川恒晟科技材料有限公司 | 一种含粉煤灰成分的石油压裂支撑剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001036638A2 (en) * | 1999-11-19 | 2001-05-25 | Curagen Corporation | Polypeptides and nucleic acids encoding same |
| JP2004504812A (ja) * | 2000-05-04 | 2004-02-19 | スージェン・インコーポレーテッド | 新規プロテアーゼ |
| AU2001292594A1 (en) * | 2000-09-08 | 2002-03-22 | Incyte Genomics, Inc. | Proteases |
| DE60129736T2 (de) * | 2000-12-18 | 2008-04-17 | Astellas Pharma Inc. | Neue aggrecanase |
-
2002
- 2002-06-04 JP JP2003502172A patent/JP2005506833A/ja active Pending
- 2002-06-04 CA CA002447935A patent/CA2447935A1/en not_active Abandoned
- 2002-06-04 EP EP02732027A patent/EP1401470A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005512515A5 (enrdf_load_stackoverflow) | ||
| JP2003505075A5 (enrdf_load_stackoverflow) | ||
| MX2008007324A (es) | Usos de antagonistas de miostatina. | |
| CZ291047B6 (cs) | Farmaceutický prostředek obsahující antagonisty faktoru růstu vaskulárních endoteliálních buněk | |
| FR2772047B1 (fr) | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection | |
| JP2004500037A5 (enrdf_load_stackoverflow) | ||
| CA2301173A1 (en) | Cysteine rich receptors-train | |
| CA2079218A1 (en) | Epithelins: novel cysteine-rich growth modulating proteins | |
| JP2001512667A (ja) | ヒトオーファンレセプターntr−1 | |
| JP4489303B2 (ja) | ニューロトロフィンおよびそのアナログを使用する、胃腸の低運動性障害の処置方法 | |
| KR950701379A (ko) | neu 수용체의 재조합 자극인자(RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR) | |
| CA2522994A1 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
| WO2016109823A1 (en) | Treatment of pediatric growth hormone deficiency with human growth hormone analogues | |
| JP2023014339A (ja) | Gdf11での処置は、体重増加を防止し、耐糖能を改善し、そして脂肪肝を低減する | |
| JP2005528080A5 (enrdf_load_stackoverflow) | ||
| JP3472587B2 (ja) | 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法 | |
| JP4654029B2 (ja) | 単一ドメインtdf関連化合物およびその類似体 | |
| JP2005506833A5 (enrdf_load_stackoverflow) | ||
| JP2004533235A5 (enrdf_load_stackoverflow) | ||
| RU97104072A (ru) | Модуляторы веса тела, соответствующие нуклеиновые кислоты и протеины, а также их применение для диагностических и терапевтических целей | |
| JP5099943B2 (ja) | ポリペプチド、ポリヌクレオチド及びその用途 | |
| JP2005504514A5 (enrdf_load_stackoverflow) | ||
| WO2002030974A2 (en) | Proteins and nucleic acids encoding same | |
| JP2005528886A5 (enrdf_load_stackoverflow) | ||
| JP2002508934A (ja) | Tnfレセプターに対して相同性を有する、新規な核酸およびポリペプチド |